par Abdel Azim, Hatem Hamdy 
;Abdel Azim, Hatem Hamdy
Référence Expert review of anticancer therapy, 13, 2, page (195-201)
Publication Publié, 2013-02
;Abdel Azim, Hatem Hamdy Référence Expert review of anticancer therapy, 13, 2, page (195-201)
Publication Publié, 2013-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Abdel Azim, Hatem Hamdy; Abdel Azim, Hatem Hamdy |
| Informations sur la publication: | Expert review of anticancer therapy, 13, 2, page (195-201) |
| Statut de publication: | Publié, 2013-02 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antibodies, Monoclonal, Humanized -- pharmacology -- therapeutic use |
| Bone Neoplasms -- drug therapy -- prevention & control -- secondary | |
| Breast Neoplasms -- pathology | |
| Female | |
| Humans | |
| Lung Neoplasms -- drug therapy -- secondary | |
| Osteoclasts -- metabolism | |
| Osteoporosis, Postmenopausal | |
| RANK Ligand -- antagonists & inhibitors -- immunology -- metabolism | |
| Receptor Activator of Nuclear Factor-kappa B -- metabolism | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7140 |
| info:doi/10.1586/era.12.177 | |
| info:pmid/23406560 |
